HomepagePRGO • NYSE
add
Perrigo
Vorige slotkoers
$Â 26,78
Dag-range
$Â 26,77 - $Â 27,19
Jaar-range
$Â 23,14 - $Â 31,32
Beurswaarde
3,69Â mld. USD
Gem. volume
1,57Â mln.
Koers/winst
-
Dividendrendement
4,29%
Primaire beurs
NYSE
In het nieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 1,04Â mld. | -3,53% |
Bedrijfskosten | 307,60Â mln. | -7,88% |
Netto inkomsten | -6,40Â mln. | -420,00% |
Netto winstmarge | -0,61 | -438,89% |
Winst per aandeel | 0,60 | 106,90% |
EBITDA | 164,60Â mln. | 56,46% |
Effectief belastingtarief | 98,80% | — |
Balans
Totale activa
Totale passiva
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 409,90Â mln. | -37,75% |
Totale activa | 9,76Â mld. | -8,28% |
Totale passiva | 5,40Â mld. | -9,36% |
Totaal aandelenvermogen | 4,36 mld. | — |
Uitstaande aandelen | 137,48 mln. | — |
Koers-boekwaardeverhouding | 0,84 | — |
Rendement op activa | 2,18% | — |
Rendement op kapitaal | 2,59% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -6,40Â mln. | -420,00% |
Operationele kasstroom | -64,50Â mln. | -4.507,14% |
Kasstroom uit beleggingen | -25,70Â mln. | -9,36% |
Kasstroom uit financiering | -61,80Â mln. | -2,32% |
Nettomutatie in liquide middelen | -148,90Â mln. | -60,45% |
Vrije kasstroom | -78,81Â mln. | -139,10% |
Over
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.
Perrigo engages in the acquisition, manufacture, and sale of consumer healthcare products, generic prescription drugs, and active pharmaceutical ingredients, primarily in the United States, from its base in Ireland. On 21 December 2018, Perrigo suffered its biggest one-day share price fall in its history after the Irish Revenue Commissioners issued a tax claim against Perrigo that equated to half of its market value. Wikipedia
Opgericht
1887
Website
Werknemers
8.379